Advances in the treatment of pediatric brain tumors

References

• Kleihues P, Louis DN, Scheithauer BW et al. The WHO classification of tumors of the nervous system. I Neuropathol Exp. Neural. 61,215-226 (2002). Excellent treatise on the breadth of tumors of the nervous system.
   Google Scholar
• Radner H, Blumcke I, Reifenberger G, Wiestler OD. The new who classification of tumors of the nervous system 2000. Pathology and genetics. Pathologe 23, 260–283 (2002).
   Google Scholar
• Ullrich NJ, Pomeroy SL. Pediatric brain tumors. Neural. Clin. 21,897–902 (2003).
   PubMed Web of Science ®Google Scholar
• Saran E Recent advances in paediatric neuro-oncology. CUI7: Opin. Neural 15, 671–677 (2002).
   Google Scholar
• Pollack IF. Pediatric brain tumors. Sem. Surgical Oncol 16,73–90 (1999).
   PubMedGoogle Scholar
• Rilliet B, Vernet O. Gliomas in children: a review. Childs Nerv. Sys. 16,735–741 (2000).
   PubMed Web of Science ®Google Scholar
• Freeman CR, Farmer JP, Montes J. Low- grade astrocytomas in children: evolving management strategies. Int. J: Racliat. Oncol Biol. Phys. 41,979-987 (1998).
   Google Scholar
• Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol 3,255–268 (1993).
   Google Scholar
• Fernandez C, Figarella-Branger D, Girard N eta]. Pilocytic astrocytomas in children: prognostic factors — a retrospective study of 80 cases. Neurosurgety53, 544–553 (2003).
   Google Scholar
• •Reiterates important factors in pilocytic astrocytomas.
   Google Scholar
• Pollack IF, Claassen D, Alshboul Q, Janosky JE, Deutsch M. Low-grade gliomas of the cerebral hemispheres in children — an analysis of 71 cases. J: Neurosurg. 82,536-547 (1995).
   Google Scholar
• Laws ERJ, Taylor WF, Clifton MB, Okazalci H. Neurosurgical management of low-grade astrocytoma of the cerebral hemisphere. Neumsurg. 61,665–673 (1984).
   Google Scholar
• Hirsch JF, Rose CS, Pierre-Kahn A. Benign astrocytic and oligodendroglial tumors of the cerebral hemispheres in children. J: Neurosurg. 70,568–572 (1989).
   PubMed Web of Science ®Google Scholar
• Mercuri S, Russo A, Palma L. Hemispheric supratentorial astrocytomas in children. Long-term results in 29 cases. J: Neumsurg. 55,170-173 (1981).
   Google Scholar
• Griffin TW, Beaufait D, Blasko JC. Cystic cerebellar astrocytomas in childhood. Cancer 44, 276–280 (1979).
   Google Scholar
• Garcia DM, Marks JE, Latin HR, Kleiefoth AB. Childhood cerebellar astrocytomas: is there a role for postoperative irradiation? int. j Racliat. Oncol Biol. Phys. 18,815–819 (1990).
   PubMedGoogle Scholar
• Conway PD, Oechler HW, Kun LE, Murray KJ. Importance of histologic condition and treatment of pediatric cerebellar astrocytomas. Cancer 67, 2772–2775 (1991).
   PubMedGoogle Scholar
• Dirks PB, Jay V, Becker LE et al. Development of anaplastic changes in low-grade astrocytomas of childhood. Neurosurgety34, 68–78 (1994). Important article which demonstrates the benign nature of low-grade astrocytoma in the absence of radiation therapy.
   Google Scholar
• Tihan T, Fisher PG, Kepner JL et al. Pediatric astrocytomas with monomorphous pilomyxoid features and a less favorable outcome. J. Neuropathol Experimental Nemo'. 58,1061–1068 (1999).
   PubMedGoogle Scholar
• Komatar RJ, Burger PC, Carson BS eta]. Pilocytic and pilomyxoid hypothalamic/ chiasmatic astrocytomas. Neurosurgety54, 72–80 (2004).
   Google Scholar
• Janss AJ, Grundy R, Cnaan A et al. Optic pathway and hypothalamic chiasmatic gliomas in children younger than age 5 years with a 6-year follow-up. Cancer75, 1051–1059 (1995).
   PubMed Web of Science ®Google Scholar
• Bruggers CS, Friedman HS, Phillips PC et al. Leptomeningeal dissemination of optic pathway gliomas in three children. Am. Ophthalmol 111,719–723 (1991).
   PubMedGoogle Scholar
• Civitello LA, Packer RJ, Rorke LB, Siegel K, Sutton LN, Schut L. Leptomeningeal dissemination of low-grade gliomas in childhood. Neurology38, 562–566 (1988).
   PubMed Web of Science ®Google Scholar
• Mamalek AN, Prados MD, Obana WG, Cogen PH, Edwards MS. Treatment options and prognosis for multicentric juvenile pilocytic astrocytoma. I Neurosurg. 81,24–30 (1994).
   Google Scholar
• Perilongo G, Carollo C, Salviati L et al. Diencephalic syndrome and disseminated juvenile pilocytic astrocytomas of the hypothalamic-optic chiasm region. Cancer 80,142–146 (1997).
   PubMedGoogle Scholar
• Bowers DC, Gargan L, Kapur P et al. Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents. j Clin. Oncol 21,2968–2973 (2003).
   Google Scholar
• Listemick R, Louis DN, Packer RJ, Gutmann DH. Optic pathway gliomas in children with neurofibromatosis.1. Consensus statement from the NF1 optic pathway glioma task force. Ann. Neural. 41, 143–149 (1997).
   Google Scholar
• Listemick R, Charrow J, Greenwald M, Mets M. Natural history of optic pathway tumors in children with neurofibromatosis type-I — a longitudinal study. J. Pediatrics 125,63–66 (1994).
   PubMedGoogle Scholar
• Pollack IE Brain tumors in children. N Engl. J. Med. 331,1500–1507 (1994).
   Google Scholar
• Alkhani AM, Boop FA, Rutka JT. Involution of enhancing intrinsic tectal tumors after endoscopic third ventriculostomy. Report of two cases. j Neurosurg. 91,863–866 (1999).
   Google Scholar
• Kihlstrom L, Lindquist C, Lindquist M, Karlsson B. Stereotactic radiosurgery for tectal low-grade gliomas. Acta Neurochir. 62(Suppl.), 55–57 (1994).
   Google Scholar
• Mottolese C, Signorelli F, Madrassy G eta]. Quadrigeminal plate tumors. A late evaluation of their surgical treatment in 25 children. Childs' Nerv. Sys. 15,421 (1999).
   Google Scholar
• Freeman CR, Farmer JP. Pediatric brain stem gliomas: a review. Int. j Radiat. Oncol Biol. Phys. 40,265–271 (1998).
   PubMed Web of Science ®Google Scholar
• Pollack IF. The role of surgery in pediatric gliomas. Ail/MOTICOi 42,271-288 (1999).
   Google Scholar
• •Helps understanding of the the classification of brainstem gliomas.
   Google Scholar
• Jennings MT, Iyengar S. Pharmacotherapy of malignant astrocytomas of children and adults — current strategies and future trends. CNS Drugs 15,719–743 (2001).
   PubMedGoogle Scholar
• Reardon DA, Gajjar A, Sanford RA eta]. Bithalamic involvement predicts poor outcome among children with thalamic glial tumors. Pediatric Neurosurgery29, 29–35 (1998).
   Google Scholar
• Bloom HJ, Glees J, Bell J. The treatment and long-term prognosis of children with intracranial tumors: a study of 610 cases 1950–1981. Int. J. Radiat. Oncol Biol. Phys. 18,723-745 (1990).
   Google Scholar
• Woo SY, Donaldson SS, Cox RS. Astrocytoma in children: 14 years' experience at Stanford University Medical Center.j Clin. Oncol 6,1001–1007 (1988).
   Google Scholar
• Bernstein M, Hoffman HJ, Halliday WC, Hendrick B, Humphreys RR Thalamic tumors in children. Long-term follow-up and treatment guidelines. J. Neurosurg. 6, 649–656 (1984).
   Google Scholar
• Rodriguez LA, Edwards MSB, Levin VA. Management of hypothalamic gliomas in children: an analysis of 33 cases. Neurosurgery26, 242–247 (1990).
   Google Scholar
• Hoffman HJ, Soloniuk DS, Humphreys RP et al. Management and outcome of low-grade astrocytomas of the midline in children: a retrospective review. Neurosurgery33, 964–971 (1993).
   PubMedGoogle Scholar
• West CGH, Gattamaneni R, Blair V. Radiotherapy in the treatment of low-grade astrocytomas 1: a survival analysis. Childs' Nerv. Sys. 11,438-442 (1995).
   Google Scholar
• Merchant TE, Zhu YP, Thompson SJ, Sontag MR, Heideman RL, Kun LE.
   Google Scholar
• Adams EJ, Suter B, Warrington AR Design guided conformal radiotherapy. Radiother. Oncol 60,289–297 (2001).
   PubMed Web of Science ®Google Scholar
• Raco A, Raimondi AJ, D’Alonzo A, Esposito V, Valentino V. Radiosurgery in the management of pediatric brain tumors. Child s Nerv. Sys. 16,287–295 (2000).
   PubMedGoogle Scholar
• Reddy AT, Packer RJ. Chemotherapy for low-grade gliomas. Child s Nerv. Sys. 15, 506–513 (1999).
   PubMedGoogle Scholar
• Packer RJ, Ater JL, Allen JC et al. Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. I Neurosurg. 86,747–754 (1997).
   PubMed Web of Science ®Google Scholar
• Pollack IE, Boyett JM, Finlay JL. Chemotherapy for high-grade gliomas of childhood. Childs Nerv. Sys. 15,529–544 (1999).
   PubMedGoogle Scholar
• Campbell JW, Pollack IF, Martinez AJ, Shultz BL. High-grade astrocytomas in children: radiologically complete resection is associated with an excellent long-term prognosis. Neumsurgety38, 258–264 (1996).
   PubMed Web of Science ®Google Scholar
• Finlay JL, Boyett JM, Yates AJ, Wisoff JH. Randomized Phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine and prednisone with the eight drugs in 1 day regimen. J. Clin. Oncol 13,112–123 (1995).
   Google Scholar
• Wisoff JH, Boyett JM, Berger MS et al. Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group Trial No. CCG-945. I Neumsurg. 89,52-59 (1998).
   Google Scholar
• Lopez-Aguilar E, Sepulveda-Vildosola AC, Rivera-Marquez H et al. Preirradiation ifosfamide, carboplatin and etoposide (ICE) for the treatment of high-grade astrocytomas in children. Childs Nerv. Sys. 19,818–823 (2003).
   PubMedGoogle Scholar
• Wolff JEA, Gnekow AK, Kortmann RD et al. Preradiation chemotherapy for pediatric patients with high-grade glioma. Cancer 94,264–271 (2002).
   PubMed Web of Science ®Google Scholar
• Finlay JL, Wisoff JH. The impact of extent of resection in the management of malignant gliomas of childhood. Childs' Nerv. Sys. 15,786–788 (1999).
   PubMed Web of Science ®Google Scholar
• Watanabe K, Tachibana O, Sata K, Yonekawa Y, Kleihues P, Ohgaki H. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain. Pathol 6,217–223 (1996).
   Google Scholar
• Rich JN, Reardon DA, Peery T et al. Phase II trial of gefitinib in recurrent glioblastoma. I Clin. Oncol 22,133–142 (2004).
   PubMed Web of Science ®Google Scholar
• Barker AJ, Gibson KH, Grundy W et al. Studies leading to the identification of ZD1839 (IRESSA): an orally-active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer. Bioorg. Med. Chem. Lett. 11,1911-1914 (2001).
   Google Scholar
• Chakravarti A, Seiferheld W Robbins I et al. Phase I results from RTOG BR-0211, a Phase VII study of an oral epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), ZD 1839 (Iressa), with radiation therapy in glioblastoma multiforme (GBM). Int. J. Radiat. Oncol Biol. Phys. 57, S329 (2003).
   Google Scholar
• •Points the way to new treatment modalities based on the known molecular pathobiology of these tumors.
   Google Scholar
• Modjtahedi H, Moscatello DK, Box G et al Targeting of cells expressing wild type EGFR and type-III mutant EGFR (EGFRVIII) by antiEGFR MAb ICR62: a two-pronged attack for tumour therapy. Int.j Cancer 105,273–280 (2003).
   Google Scholar
• Mischel PS, Cloughesy TF. Targeted molecular therapy of GBM. Brain Pathol 13,52–61 (2003).
   PubMed Web of Science ®Google Scholar
• ••Reviews the novel molecular therapies forthe treatment of glioblastoma multiforrne. Covers a wide spectrum of different possible therapeutic targets.
   Google Scholar
• Wu G, Barth RF, Yang W eta]. Site-specific conjugation of boron-containing dendrimers to antiEGF receptor monoclonal antibody cetuximab (IMC—C225) and its evaluation as a potential delivery agent for neutron capture therapy. Biocohjug. Chem. 15, 185–194 (2004).
   Google Scholar
• Mautner VP Tatagiba M, Guthoff R, Samii M, Pulst SM. Neurofibromatosis 2 in the pediatric age group. Neumsurgery33, 92–96 (1993).
   PubMedGoogle Scholar
• Sieb JP, Pulst SM, Buch A. Familial CNS tumors. J. Neural. 239,343–344 (1992).
   Google Scholar
• Teo C, Nakaji P, Symons P, Tobias V, Cohn R, Smee R. Ependymoma. Childs Nerv Sys. 19,270–285 (2003).
   PubMedGoogle Scholar
• Grabb PA, Albright AL, Pang D. Dissemination of supratentorial malignant gliomas via the cerebrospinal fluid in children. Neurosurgery30,64–71 (1992).
   Google Scholar
• Ito U, Tomita H, Yamazaki S, Takada Y, Inaba Y. CT findings of leptomeningeal and periventricular dissemination of tumors. Report of four cases. Gun. Neural Neurosurg. 88,115–120 (1986).
   Google Scholar
• Naganska E, Matyja E, Zabek M, Jagielski J. Disseminated spinal and cerebral ependymoma with unusual histological pattern: clinicopathological study of a case with retrograde tumor spread. Folia Neuropathol 38,135–141 (2000).
   PubMedGoogle Scholar
• Carbone M, Rizzo P, Pass HI. Simian virus 40, poliovaccines and human tumors: a review of recent developments. Oncogene 15,1877–1888 (1997).
   Google Scholar
• Croul S, Otte J, Khalili K. Brain tumors and polyomaviruses. j Neurovirol 9, 173–182 (2003).
   Google Scholar
• Zhen HN, Zhang X, Bu XY et al. Expression of the simian virus 40 large tumor antigen (Tag) and formation of Tag-p53 and Tag-pRb complexes in human brain tumors. Cancer 86,2124–2132 (1999).
   PubMedGoogle Scholar
• Kirchstein RL, Rabson AS, O'Conor GT. Ependymomas produced in Syrian hamsters by adenovirus 7, strain E46 (hybrid of adenovirus 7 and 5V40). Proc. Soc. Exp. Biol. Merl 120,484–487 (1965).
   Google Scholar
• Kirschstein RL, Gerber P. Ependymomas produced after intracerebral inoculation of 5V40 into new-born hamsters. Nature 195, 299–300 (1962).
   PubMedGoogle Scholar
• Huang B, Starostik P, Kuhl J, Tonn JC, Roggendorf W Loss of heterozygosity on chromosome 22 in human ependymomas. Acta Neuropathol 103,415–420 (2002).
   PubMedGoogle Scholar
• Koschny R, Koschny T, Froster UG, Krupp W, Zuber MA. Comparative genomic hybridization in glioma: a meta-analysis of 509 cases. Cancer Genet. Cytogenet. 135, 147–159 (2002).
   Google Scholar
• Yokota T, Tachizawa T, Fukino K et al. A family with spinal anaplastic ependymoma: evidence of loss of chromosome 22q in tumor. Hum. Genet. 48,598-602 (2003).
   Google Scholar
• Jeuken JW, Sprenger SH, Gilhuis J, Teepen HL, Grotenhuis AJ, Wesseling Correlation between localization, age, and chromosomal imbalances in ependymal tumours as detected by CGH. I Pathol 197,238–244 (2002).
   Google Scholar
• Ebert C, von Haken M, Meyer-Puttlitz B et al Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas. Am. Pathol 155,627–632 (1999).
   Google Scholar
• Grill J, Avet-Loiseau H, Lellouch-Tubiana A et al. Comparative genomic hybridization detects specific cytogenetic abnormalities in pediatric ependymomas and choroid plexus papillomas. Cancer Genet. Cytogenet. 136, 121–125 (2002).
   PubMedGoogle Scholar
• Carter M, Nicholson J, Ross F et al. Genetic abnormalities detected in ependymomas by comparative genomic hybridisation. BE J. Cancer 86,929–939 (2002).
   Google Scholar
• Granzow M, Popp S, Weber S et al. Isochromosome lq as an early genetic event in a child with intracranial ependymoma characterized by molecular cytogenetics. Cancer Genet. Cytogenet. 130,79–83 (2001).
   PubMedGoogle Scholar
• Ward S, Harding B, Wilkins P et al. Gain of lq and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymoma. Genes Chromosomes Cancer 32,59–66 (2001).
   PubMed Web of Science ®Google Scholar
• Gilbertson RJ, Bentley L, Hernan R et al ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease. Clin. Cancer Res. 8, 3054–3064 (2002).
   PubMed Web of Science ®Google Scholar
• Bortolotto S, Chiado-Piat L, Cavalla P, Bosone I, Mauro A, Schiffer D. CDKN2A/ p16 in ependymomas. j Neurooncol 54, 9–13 (2001).
   PubMedGoogle Scholar
• Rousseau E, Ruchoux MM, Scaravilli F et al. CDKN2A, CDKN2B and p14ARF are frequently and differentially methylated in ependymal tumours. Neuropathol Appl Neurobial 29,574–583 (2003).
   PubMed Web of Science ®Google Scholar
• Friedman JA, Wetjen NM, Atkinson JL. Utility of intraoperative ultrasound for tumors of the cauda equina. Spine 28, 288–291 (2003).
   Google Scholar
• Emestus RI, Schroder R, Stutzer H, Klug N. Prognostic relevance of localization and grading in intracranial ependymomas of childhood. Childs Nerv. Sys. 12,522–526 (1996).
   PubMedGoogle Scholar
• Sutton LN, Goldwein J, Perilongo G et al. Prognostic factors in childhood ependymomas. Pecliatr Neurosurg. 16, 57–65 (1990).
   PubMed Web of Science ®Google Scholar
• Robertson PL, Zeltzer PM, Boyett JM eta]. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group. I Neurosurg. 88, 695–703 (1998).
   PubMed Web of Science ®Google Scholar
• Sutton LN, Goldwein J, Perilongo G et al. Prognostic factors in childhood ependymomas. Pediatric Neurosurg. 16, 57–65 (1990).
   PubMed Web of Science ®Google Scholar
• Pollack IF, Gerszten PC, Martinez AJ et al. Intracranial ependymomas of childhood: long-term outcome and prognostic factors. Neurosurgery37, 655–666 (1995). Highlights the important factors in ependymoma, especially the importance of residual disease.
   Google Scholar
• Rezai AR, Woo HH, Lee M, Cohen H, Zagzag D, Epstein FJ. Disseminated ependymomas of the central nervous system. I Neurosurg. 85,618–624 (1996).
   PubMed Web of Science ®Google Scholar
• Mansur DB, Drzymala RE, Rich KM, Klein EE, Simpson JR. The efficacy of stereotactic radiosurgery in the management of intracranial ependymoma. Neurooncol 66,187–190 (2003).
   Google Scholar
• Endo H, Kumabe T, Jokura H, Shirane R, Tominaga T Stereotactic radiosurgery for nodular dissemination of anaplastic ependymoma. Acta Neurochir 146, 291–298 (2004).
   PubMedGoogle Scholar
• Weil MD. Advances in stereotactic radiosurgery for brain neoplasms. CI.117: Neural. Neurosci. Rep. 1,233-237 (2001).
   Google Scholar
• Hodgson DC, Goumnerova LC, Loeffler JS eta]. Radiosurgery in the management of pediatric brain tumors. int. j Radiat. Oncol Biol. Phys. 50,929–935 (2001).
   PubMed Web of Science ®Google Scholar
• Adamson TE. Craniopharyngiomas. Neurosurgery39, 1070–1071 (1996).
   PubMedGoogle Scholar
• Adamson TE, Wiestler OD, Kleihues P, Yasargil MG. Correlation of clinical and pathological features in surgically treated craniopharyngiomas. I Neumsurg. 73, 12–17 (1990).
   PubMed Web of Science ®Google Scholar
• Vargas JR, Pino JA, Murad TM. Craniopharyngioma in two siblings. JAIVIA 246,1807–1808 (1981).
   Google Scholar
• Boch AL, van Effenterre R, Kujas M. Craniopharyngiomas in two consanguineous siblings: case report. Neurosurgery41, 1185–1187 (1997).
   PubMed Web of Science ®Google Scholar
• Van Effenterre R, Boch AL. Craniopharyngioma in adults and children: a study of 122 surgical cases. j Neumsurg. 97,3–11 (2002).
   PubMedGoogle Scholar
• Rashidi M, DaSilva VR, Minagar A, Rutka JT Nonmalignant pediatric brain tumors. Curl: Neural Neurosci. Rep. 3,200–205 (2003).
   Google Scholar
• Kepes JJ, Chen WY, Pang LC, Kepes M. Tumors of the central nervous system in Taiwan, Republic of China. Surg. Neural 22,149–156 (1984).
   PubMed Web of Science ®Google Scholar
• Yasargil MG, Curcic M, Siegenthaler G, Teddy PJ, Roth P Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients. I Neumsurg. 73,3-11 (1990).
   Google Scholar
• Kulkami V, Daniel RT, Pranatartiharan R. Spontaneous intraventricular rupture of craniopharyngioma cysts. Surg. Neural 54, 249–253 (2000).
   Google Scholar
• Nishio Y, Takashima S, Taguchi Y etal. A case of craniopharyngioma with chemical meningitis as an initial symptom. No. To. Shinkei. 53,957–960 (2001).
   Google Scholar
• Hayward R. The present and future management of childhood craniopharyngioma. Child s Nary. Sys. 15, 764–769 (1999).
   PubMedGoogle Scholar
• Rienstein S, Adams EF, Pilzer D, Goldring AA, Goldman B, Friedman E. Comparative genomic hybridization analysis of craniopharyngiomas. I Neumsurg. 98, 162–164 (2003).
   PubMed Web of Science ®Google Scholar
• Rickert CH, Paulus W Lack of chromosomal imbalances in adamantinomatous and papillary craniopharyngiomas. j Neural Neurosurg. PTchiarry74, 260–261 (2003).
   PubMedGoogle Scholar
• Karnes PS, Tran TN, Cui MY eta]. Cytogenetic analysis of 39 pediatric central nervous system tumors. Cancer Genet. Cyrogener. 59,12-19 (1992).
   Google Scholar
• Hoffman HJ. Surgical management of craniopharyngioma. Pedlarl: Neurosurg. 21\(Suppl. 1), 44–49 (1994).
   Google Scholar
• Hoffman HJ, De Silva M, Humphreys RP, Drake JM, Smith ML, Blaser SI. Aggressive surgical management of craniopharyngiomas in children. j Neurosurg. 76,47-52 (1992). iii Regine WF, Mohiuddin M, Kramer S. Long-term results of pediatric and adult craniopharyngiomas treated with combined surgery and radiation. Radiother. Oncol 27, 13–21 (1993).
   Google Scholar
• Rajan B, Ashley S, Gorman C eta]. Craniopharyngioma-a long-term results following limited surgery and radiotherapy. Radiother. Oncol 26,1–10 (1993).
   Google Scholar
• Stripp DC, Maity A, Jams AJ eta]. Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults. int. j Radiat. Oncol Biol. fiy. 58,714–720 (2004).
   Google Scholar
• Kalapuralcal JA, Goldman S, Hsieh YC, Tomita T, Marymont MET. Clinical outcome in children with craniopharyngioma treated with primary surgery and radiotherapy deferred until relapse. Med. Pedlarl: 0=1 40, 214–218 (2003).
   Google Scholar
• Van den Berge JH, Blaauw G, Breeman WA, Rahmy A, Wijngaarde R. Intracavitary brachytherapy of cystic craniopharyngiomas. I Neurosurg 77, 545–550 (1992).
   PubMedGoogle Scholar
• Cavalheiro S, Sparapani FV, Franco JO, da Silva MC, Braga FM. Use of bleomycin in intratumoral chemotherapy for cystic craniopharyngioma. Case report. J. Neurosurg. 84,124–126 (1996).
   Google Scholar
• Sagoh M, Murakami H, Hirose Y, Mayanagi K. Occlusive cerebrovasculopathy after internal radiation and bleomycin therapy for craniopharyngioma-case report. Neural. Med. Chir. 37,920–923 (1997).
   PubMedGoogle Scholar
• Savas A, Erdem A, Tun K, Kanpolat Y. Fatal toxic effect of bleomycin on brain tissue after intracystic chemotherapy for a craniopharyngioma: case report. Neurosurgery46, 213–217 (2000).
   PubMedGoogle Scholar
• Amendola BE, Wolf A, Coy SR, Amendola MA. Role of radiosurgery in craniopharyngiomas: a preliminary report. Med. Pedlarl: Oncol 41,123–127 (2003).
   PubMedGoogle Scholar
• Jackson AS, St George EJ, Hayward RJ, Plowman PN. Stereotactic radiosurgery. XVII: Recurrent intrasellar craniopharyngioma. Br. J. Neurosurg. 17, 138–143 (2003).
   Google Scholar
• Ulfarsson E, Lindquist C, Roberts M et al. Gamma knife radiosurgery for craniopharyngiomas: long-term results in the first Swedish patients. I Neumsurg. 97, 613–622 (2002).
   PubMed Web of Science ®Google Scholar
• Arseni C, Ciurea AV Statistical survey of 276 cases of medulloblastoma (1935-1978). Acta Neurochir. 57,159–162 (1981).
   PubMed Web of Science ®Google Scholar
• Deen DF, Chiarodo A, Grimm EA et al. Brain Tumor Working Group Report on the 9th International Conference on Brain Tumor Research and Therapy. Organ System Program, National Cancer Institute. I Neurooncol 16,243–272 (1993).
   Google Scholar
• Packer RJ, Goldwein J, Nicholson HS et al Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: a Children's Cancer Group Study.I Clin. Oncol 17,2127–2136 (1999).
   PubMed Web of Science ®Google Scholar
• ••Important article demonstrating the trendtoward decreased radiation doses for average-risk medulloblastoma.
   Google Scholar
• Goldwein JW, Radcliffe J, Johnson J et al. Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma). Int. J. Radiat. Oncol Biol. Phys. 34,899–904 (1996).
   PubMed Web of Science ®Google Scholar
• Packer RJ, Sutton ME, Elterman RD. Outcome for children with medulloblastoma treated with radiation and cisplain, CCNU and vincristine chemotherapy. J. Neurosurg. 81,690–698 (1994).
   Google Scholar
• Spiegler BJ, Bouffet E, Greenberg ML, Rutka JT, Mabbott DJ. Change in neurocognitive functioning after treatment with cranial radiation in childhood. I. Clin. Oncol 22,706–713 (2004).
   Google Scholar
• Gilbertson R, Wickramasinghe C, Hernan R et al. Clinical and molecular stratification of disease risk in medulloblastoma. Br. J. Cancer85, 705–712 (2001).
   PubMed Web of Science ®Google Scholar
• Grotzer MA, Jams AJ, Fung K et al. TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors. Clin. Oncol 18,1027–1035 (2000).
   Google Scholar
• Gilbertson RJ, Pearson AD. Prognostic significance of the c-erb-B2 oncogene product in childhood medulloblastoma. Br. J. Cancer 71,473–477 (1995).
   Google Scholar
• Pomeroy SL, Tamayo P, Gaasenbeek M et al Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415,436–442 (2002).
   PubMed Web of Science ®Google Scholar
• •Demonstrates the power of novel molecular techniques such as microarrays in stratifying similar tumor types. Molecular techniques such as these may be used in the future to direct therapies.
   Google Scholar
• Raffel C, Jenkins RB, Frederick L eta]. Sporadic medulloblastomas contain PTCH mutations. Cancer Res. 57,842–845 (1997).
   Google Scholar
• Taylor MD, Liu L, Raffel C eta]. Mutations in SUFU predispose to medulloblastoma. Nature Genet. 31, 306–310 (2002).
   PubMed Web of Science ®Google Scholar
• Taipale J, Chen JK, Cooper MK et al Effects of oncogenic mutations in smoothened and patched can be reversed by cyclopamine. Nature 406,1005–1009 (2000).
   PubMed Web of Science ®Google Scholar
• Chen JK, Taipale J, Young KE, Maiti T, Beachy PA. Small molecule modulation of Smoothened activity. Proc. Natl Acad. Sc]. USA 99,14071–14076 (2002).
   PubMed Web of Science ®Google Scholar
• Chen JK, Taipale J, Cooper MK, Beachy PA. Inhibition of hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev. 16,2743–2748 (2002).
   PubMed Web of Science ®Google Scholar
• Berman DM, Karhadkar SS, Hallahan AR et al Medulloblastoma growth inhibition by hedgehog pathway blockade. Science 297,1559–1561 (2002).
   PubMed Web of Science ®Google Scholar
• •Shows the potential of drugs that modulate the hedgehog signaling pathway in the treatment of medulloblastoma. Although most of the data presented represents a murine model, there is one figure showing the effectiveness of cyclopamine on human medullblastoma.
   Google Scholar
• Reifenberger J, Wolter M, Weber RG et al. Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res. 58, 1798–1803 (1998).
   PubMed Web of Science ®Google Scholar
• Albright AL, Packer RJ, Zimmerman RA, Rorke LB, Boyett JM, Hammond GD. Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children's Cancer Group. Neumsurgety33, 1026–1030 (1993).
   PubMed Web of Science ®Google Scholar
• Hoffman JM. New advances in brain tumor imaging. CUI7: Opin. Oncol 13, 148–153 (2001).
   Google Scholar
• Kaibara T, Tyson RL, Sutherland GR. Human cerebral neoplasms studied using MR spectroscopy: a review. Biochem. Cell Biol. 76,477-486 (1998).
   Google Scholar
• Preul MC, Caramanos Z, Collins DL, Pokrupa R, Arnold DL. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nature Med. 2,317–325 (1996).
   Google Scholar
• Tamiya T, Kinoshita K, Ono Y, Matsumoto K, Furuta T, Ohmoto T Proton magnetic resonance spectroscopy reflects cellular proliferative activity in astrocytomas. Neuroracliology 42, 333–338 (2000).
   PubMed Web of Science ®Google Scholar
• Schlemmer HP, Bachert P, Henze M eta]. Differentiation of radiation necrosis from tumor progression using proton magnetic resonance spectroscopy. Neuroracliology 44, 216–222 (2002).
   Google Scholar
• McKnight TR, von dem Bussche MET, Vigneron DB et al Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. I Neurosurg. 97, 794–802 (2002).
   PubMed Web of Science ®Google Scholar
• Hendler T, Pianka P, Sigal M et al Delineating gray and white matter involvement in brain lesions: three-dimensional alignment of functional magnetic resonance and diffusion-tensor imaging. Aiyliusurg. 99,1018–1027 (2003).
   Google Scholar
• Clark CA, Barrick TR, Murphy MM, Bell BA. White matter fiber tracking in patients with space-occupying lesions of the brain: a new technique for neurosurgical planning? Neuroimage 20,1601–1608 (2003).
   PubMed Web of Science ®Google Scholar
• Keles GE, Lundin DA, Lamborn KR, Chang EF, Ojemann G, Berger MS. Intraoperative subcortical stimulation mapping for hemispherical perirolandic gliomas located within or adjacent to the descending motor pathways: evaluation of morbidity and assessment of functional outcome in 294 patients. I Neurosurg. 100, 369–375 (2004).
   PubMedGoogle Scholar
• Henry RG, Berman JI, Nagarajan SS, Mukherjee P, Berger MS. Subcortical pathways serving cortical language sites: initial experience with diffusion tensor imaging fiber tracking combined with intraoperative language mapping. Neuroimage 21,616–622 (2004).
   PubMed Web of Science ®Google Scholar